Prime-boost H7N9 influenza vaccine concept promising in clinical trial With hopes of making one dose of an inactivated H7N9 vaccine fully protective, scientists successfully tested a prime-boost concept in a small clinical trial. The 'primer' vaccine introduces the immune system to H7N9 influenza virus, and subsequent vaccination with the 'booster' inactivated virus vaccine promotes a better immune response.
New blood test could predict arthritis risk early Testing for antibodies that target citrullinated tenascin-C (cTNC) could diagnose rheumatoid arthritis in around 50 percent of cases, including some cases not identified by current best tests. It also has a very low rate of false positives -- 98 percent accurate at ruling out rheumatoid arthritis.
New concussion treatment could change how head injuries are treated The standard of care for acute concussion may undergo a dramatic change, depending on the results of a new exercise treatment that physicians have developed and begun testing. It is the first randomized, controlled clinical trial of this exercise treatment for concussion.
Happiness and unhappiness have no direct effect on mortality Happiness itself has no direct effect on mortality, a study of a million UK women has shown. Further, the widespread but mistaken belief that unhappiness and stress directly cause ill health came from studies that had simply confused cause and effect,